Neural correlates of sleepiness induced by catecholamine depletion

Psychiatry Research - Neuroimaging

Volumn 194, Issue 1, 2011, Pages 73-78

  Meyers, Noah ^a   Fromm, Stephen ^a   Luckenbaugh, David A ^a   Drevets, Wayne C ^b   Hasler, Gregor ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b LAUREATE INSTITUTE FOR BRAIN RESEARCH   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Dopamine; Hypothalamus; Mesencephalon; Norepinephrine; Prolactin; Sleep

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METIROSINE; PROLACTIN;

ADULT; ARTICLE; BRAIN METABOLISM; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; INSULA; MAJOR DEPRESSION; MALE; NERVE CELL; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NORMAL HUMAN; ORBITAL CORTEX; PERIAQUEDUCTAL GRAY MATTER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; TEMPORAL CORTEX;

ADOLESCENT; ADULT; AMPHETAMINE; BRAIN; BRAIN MAPPING; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 80053384372     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.06.015     Document Type: Article

References (53)

1. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., Weiss R., Cooper T.B., Mann J.J., Van Heertum R.L., Gorman J.M., Laruelle M. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:8104-8109.
2. Andretic R., van Swinderen B., Greenspan R.J. Dopaminergic modulation of arousal in Drosophila. Current Biology 2005, 15:1165-1175.
3. Aston-Jones G., Bloom F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J The Journal of Neuroscience 1981, 1:876-886.
4. Bamford N.S., Zhang H., Schmitz Y., Wu N.P., Cepeda C., Levine M.S., Schmauss C., Zakharenko S.S., Zablow L., Sulzer D. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 2004, 42:653-663.
5. Berlucchi G. One or many arousal systems? Reflections on some of Giuseppe Moruzzi's foresights and insights about the intrinsic regulation of brain activity. Archives Italiennes de Biologie 1997, 135:5-14.
6. Berman R.M., Narasimhan M., Miller H.L., Anand A., Cappiello A., Oren D.A., Heninger G.R., Charney D.S. Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?. Archives of General Psychiatry 1999, 56:395-403.
7. Berridge C.W., Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Research Brain Research Reveiws 2003, 42:33-84.
8. Boutrel B., Koob G.F. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 2004, 27:1181-1194.
9. Bremner J.D., Vythilingam M., Chin K.N., Vermetten E., Nazeer A., Oren D., Berman R.M., Charney D.S. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms. Journal of the American Medical Association 2003, 289:3125-3134.
10. Carskadon M.A., Cavallo A., Rosekind M.R. Sleepiness and nap sleep following a morning dose of clonidine. Sleep 1989, 12:338-344.
11. Cropley V.L., Innis R.B., Nathan P.J., Brown A.K., Sangare J.L., Lerner A., Ryu Y.H., Sprague K.E., Pike V.W., Fujita M. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Synapse 2008, 62:399-408.
12. Curcio G., Casagrande M., Bertini M. Sleepiness: evaluating and quantifying methods. International Journal of Psychophysiology 2001, 41:251-263.
13. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. Journal of Neuroscience 1992, 12:3628-3641.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2001, Biometrics Research, New York State Psychiatric Institute, New York.
15. Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiological Reviews 2000, 80:1523-1631.
16. Graybiel A.M. Basal ganglia-input, neural activity, and relation to the cortex. Current Opinion in Neurobiology 1991, 1:644-651.
17. Hasler G., Drevets W.C., Manji H.K., Charney D.S. Discovering endophenotypes for major depression. Neuropsychopharmacology 2004, 29:1765-1781.
18. Hasler G., Buysse D.J., Gamma A., Ajdacic V., Eich D., Rossler W., Angst J. Excessive daytime sleepiness in young adults: a 20-year prospective community study. Journal of Clinical Psychiatry 2005, 66:521-529.
19. Hasler G., Fromm S., Carlson P.J., Luckenbaugh D.A., Waldeck T., Geraci M., Roiser J.P., Neumeister A., Meyers N., Charney D.S., Drevets W.C. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of General Psychiatry 2008, 65:521-531.
20. Hasler G., Luckenbaugh D.A., Snow J., Meyers N., Waldeck T., Geraci M., Roiser J., Knutson B., Charney D.S., Drevets W.C. Reward processing after catecholamine depletion in unmedicated, remitted subjects with major depressive disorder. Biological Psychiatry 2009, 66:201-205.
21. Herscovitch J., Broughton R. Sensitivity of the Stanford sleepiness scale to the effects of cumulative partial sleep deprivation and recovery oversleeping. Sleep 1981, 4:83-91.
22. Hoddes E., Dement W.C., Zarcone V. Quantification of sleepiness: a new approach. Psychophysiology 1973, 10:431-436.
23. Horne J.A., Reyner L.A. Sleep related vehicle accidents. British Medical Journal 1995, 310:565-567.
24. Hoshi E., Sawamura H., Tanji J. Neurons in the rostral cingulate motor area monitor multiple phases of visuomotor behavior with modest parametric selectivity. Journal of Neurophysiology 2005, 94:640-656.
25. Jones B.E., Bobillier P., Pin C., Jouvet M. The effect of lesions of catecholamine-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat. Brain Research 1973, 58:157-177.
26. Lai Y.Y., Shalita T., Hajnik T., Wu J.P., Kuo J.S., Chia L.G., Siegel J.M. Neurotoxic N-methyl-d-aspartate lesion of the ventral midbrain and mesopontine junction alters sleep-wake organization. Neuroscience 1999, 90:469-483.
27. Laruelle M., D'Souza C.D., Baldwin R.M., Abi-Dargham A., Kanes S.J., Fingado C.L., Seibyl J.P., Zoghbi S.S., Bowers M.B., Jatlow P., Charney D.S., Innis R.B. Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 1997, 17:162-174.
28. Léger D. The cost of sleep-related accidents: a report for the National Commission on Sleep Disorders Research. Sleep 1994, 17:84-93.
29. Léger L., Sapin E., Goutagny R., Peyron C., Salvert D., Fort P., Luppi P.H. Dopaminergic neurons expressing Fos during waking and paradoxical sleep in the rat. Journal of Chemical Neuroanatomy 2010, 39:262-271.
30. Lu J., Jhou T.C., Saper C.B. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. Journal of Neuroscience 2006, 26:193-202.
31. Lu J., Sherman D., Devor M., Saper C.B. A putative flip-flop switch for control of REM sleep. Nature 2006, 441:589-594.
32. Magistretti P.J., Pellerin L., Rothman D.L., Shulman R.G. Energy on demand. Science 1999, 283:496-497.
33. Martinez D., Greene K., Broft A., Kumar D., Liu F., Narendran R., Slifstein M., Van Heertum R., Kleber H.D. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. American Journal of Psychiatry 2009, 166:1170-1177.
34. McCann U.D., Penetar D.M., Shaham Y., Thorne D.R., Gillin J.C., Sing H.C., Thomas M.A., Belenky G. Sleep deprivation and impaired cognition. Possible role of brain catecholamines. Biological Psychiatry 1992, 31:1082-1097.
35. McCarley R.W. Neurobiology of REM and NREM sleep. Sleep Medicine 2007, 8:302-330.
36. Mignot E., Laude D. Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosine. Journal of Neurochemistry 1985, 45:1527-1533.
37. Miller J.D., Farber J., Gatz P., Roffwarg H., German D.C. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Research 1983, 273:133-141.
38. Moore K.E. Interactions between prolactin and dopaminergic neurons. Biology of Reproduction 1987, 36:47-58.
39. Moore D.F., Altarescu G., Barker W.C., Patronas N.J., Herscovitch P., Schiffmann R. White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions. Brain Research Bulletin 2003, 62:231-240.
40. Nagatsu T., Levitt M., Udenfriend S. Tyrosine Hydroxylase. The Initial Step in Norepinephrine Biosynthesis. Journal of Biological Chemistry 1964, 239:2910-2917.
41. Neumeister A., Nugent A.C., Waldeck T., Geraci M., Schwarz M., Bonne O., Bain E.E., Luckenbaugh D.A., Herscovitch P., Charney D.S., Drevets W.C. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of General Psychiatry 2004, 61:765-773.
42. Ongur D., Ferry A.T., Price J.L. Architectonic subdivision of the human orbital and medial prefrontal cortex. Journal of Comparative Neurology 2003, 460:425-449.
43. Qu W.M., Huang Z.L., Xu X.H., Matsumoto N., Urade Y. Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. Journal of Neuroscience 2008, 28:8462-8469.
44. Riccardi P., Baldwin R., Salomon R., Anderson S., Ansari M.S., Li R., Dawant B., Bauernfeind A., Schmidt D., Kessler R. Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride. Biological Psychiatry 2008, 63:241-244.
45. Rye D.B., Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002, 58:341-346.
46. Sara S.J. The locus coeruleus and noradrenergic modulation of cognition. Nature Reviews Neuroscience 2009, 10:211-223.
47. Stine S.M., Krystal J.H., Petrakis I.L., Jatlow P.I., Heninger G.R., Kosten T.R., Charney D.S. Effect of alpha-methyl-para-tyrosine on response to cocaine challenge. Biological Psychiatry 1997, 42:181-190.
48. Talairach J., Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain 1988, Georg Thieme Verlag, Stuttgart.
49. Trulson M.E., Preussler D.W., Howell G.A. Activity of substantia nigra units across the sleep-waking cycle in freely moving cats. Neuroscience Letters 1981, 26:183-188.
50. Verhoeff N.P., Kapur S., Hussey D., Lee M., Christensen B., Psych C., Papatheodorou G., Zipursky R.B. A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Neuropsychopharmacology 2001, 25:213-223.
51. Verhoeff N.P., Christensen B.K., Hussey D., Lee M., Papatheodorou G., Kopala L., Rui Q., Zipursky R.B., Kapur S. Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study. Pharmacology, Biochemistry, and Behavior 2003, 74:425-432.
52. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. Journal of Neuroscience 2001, 21:1787-1794.
53. Wooten G.F., Collins R.C. Metabolic effects of unilateral lesion of the substantia nigra. Journal of Neuroscience 1981, 1:285-291.